Maharashtra on Wednesday registered as many as 81 fresh Covid-19 cases and one death, the state health department said, reported the PTI.

The tally of patients infected with the JN.1 sub-variant has risen to 451 so far, the department said, according to the PTI.

The sole fatality was reported from Pune city. The Covid-19 fatality rate in Maharashtra currently stands at 1.81 per cent, it said.

Mumbai registered 26 fresh cases, reported the PTI.

At 189, Pune leads the tally of patients found to be infected by the JN.1 sub-variant of Omicron in the state.

Pune is followed by Thane (89 cases of JN.1 sub-variant), Mumbai (37), Chhatrapati Sambhaji Nagar (31), Nagpur (30), Raigad (13), Solapur and Amravati (9), Sangli and Kolhapur (7), Ratnagiri (5), Jalgaon and Hingoli (4), Ahmadnagar and Beed (3), Nanded, Nashik and Dharashiv (2), and one each in Akola, Satara, Sindhudurg Yavatmal and Nandurbar, as per the health department.

A total of 97 people were discharged in Maharashtra on Wednesday at a recovery rate of 98.18 per cent.

A total of 12,269 tests were conducted in the last 24 hours of which 1,783 were RT-PCR and 10,486 were Rapid Antigen Tests. The current positivity rate stands at 0.66 per cent, the department said, as per the PTI.

Meanwhile, India saw a single-day rise of 269 new cases of Covid-19, while the number of active cases of the infection has declined to 2,556, the health ministry said on Wednesday.

Three deaths, two from Kerala and one from Maharashtra have been reported in the last 24 hours, according to the ministry`s data updated at 8 am.

The number of daily cases had dropped to double-digits till December 5, but cases began to increase after the emergence of a new variant and cold weather conditions.

After December 5, a maximum of a single-day rise of 841 new cases was reported on December 31, 2023, which is 0.2 per cent of the peak cases reported in May 2021, official sources said.

Of the total active cases, around 92 per cent are recovering under home isolation.

“The currently available data suggests that the JN.1 sub-variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality,” the official source stated.

(with PTI inputs)

Source link